Kuros Biosciences AG ( CSBTF) - Key Metrics
CSBTF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.83 | $0.09 | -$0.06 | -$0.19 |
| 2025Q4 | $1.69 | $0.09 | $0.05 | $0.02 |
| 2025Q2 | $1.59 | -$0.05 | -$0.07 | -$0.09 |
| 2024Q4 | $1.18 | -$0.09 | $0.09 | $0.08 |
| 2024Q2 | $0.86 | -$0.01 | -$0.01 | -$0.02 |
CSBTF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 51.94 |
| 2025Q4 | 0% | 79.86 |
| 2025Q2 | 0% | -137.13 |
| 2024Q4 | 0% | -54.37 |
| 2024Q2 | 0% | -550.44 |
CSBTF
Price: $26.99
52 week price:
Earnings Per Share: 0.23 USD
P/E Ratio: 117.35
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 1.1 billion